Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:22 PM
Ignite Modification Date:
2025-12-24 @ 7:22 PM
NCT ID:
NCT01599403
Eligibility Criteria:
Eligibility Criteria
A subject must meet the following criteria to take part in the study:
Inclusion Criteria
* Subjects 18 years of age and greater
* Inpatient on the BWH SICU, MICU, or hospital floor ward
* Non-intubated at the time of block placement
* Traumatic Rib Fractures three or greater
* Block able to be placed within 12-24 hours of presentation to the emergency room
* Ability to provide written informed consent.
* Compliance with all ASRA and BWH Regional Anesthesia in Anticoagulated Patient guidelines for coagulation status.
Exclusion Criteria:
* Subject is pregnant
* Subject not expected to survive 48 hours due to traumatic injuries
* Allergy to Ropivacaine or other local anesthetic
* Any significant concomitant injuries potentially confounding data acquisition (e.g., traumatic brain injury, long bone fractures, intra-abdominal injuries)
* Known allergy to lidocaine
* Inability to provide written, informed consent
* Known opioid medication dependence
* Non-compliance with ARSA and BWH Regional Anesthesia in Anticoagulated Patient Guidelines.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT01599403
Study Brief:
Protocol Section:
NCT01599403